New device aims to prevent leg damage during heart surgery

NCT ID NCT07163234

Recruiting now Disease control Sponsor: IPERF SAS Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage study tests a new tube (cannula) placed in the leg artery during heart surgery that uses a heart-lung machine. The device is designed to keep blood flowing to the leg, reducing the risk of limb damage. Fifteen adults having planned heart surgery will be enrolled, and the main goal is to check safety over 30 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: IPERF femoral arterial cannula (a dual-lumen device for lower limb perfusion during heart surgery)
What this could lead to: If it works, this could lead to a safer way to do heart surgery that uses leg arteries, reducing the risk of leg complications.
What could go wrong: This is a very early, small study (15 people) testing only safety and feasibility. The device may not work as hoped, and unexpected side effects could occur.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic disease limb ischemia prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIAC SURGERY ISCHEMIA LIMB

Contacts and locations

Locations

Hopital Jacques Cartier - Ramsay Santé
RECRUITING

Massy, France
Hôpital privé Jacques Cartier - Ramsay Santé
NOT_YET_RECRUITING

Massy, 91300, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.